Enterprise Value
1.052B
Cash
176.6M
Avg Qtr Burn
-51.71M
Short % of Float
0.06%
Insider Ownership
0.00%
Institutional Own.
0.78%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
IXCHIQ (VLA1553) Details Chikungunya, Infectious disease | Approved Quarterly sales | |
IXCHIQ (VLA1553) Details Chikungunya, Viral infection | Phase 3 Update | |
IXCHIQ (VLA1553) Details Chikungunya, Viral infection | Phase 3 Initiation | |
IXCHIQ (VLA1553) Details Chikungunya, Viral infection | Phase 2 Data readout | |
VLA15 Details Bacterial infection, Lyme disease | Phase 2 Data readout | |
VLA1601 Details Viral infection, Zika virus | Phase 1 Data readout | |
VLA2001 Details Infectious disease, COVID-19 | Failed Discontinued |